MR in Clinical Diabetes Research and Drug Trials

2018 ◽  
Vol 103 (3) ◽  
pp. 809-812 ◽  
Author(s):  
Boris Draznin ◽  
Peter A Kahn ◽  
Nicole Wagner ◽  
Irl B Hirsch ◽  
Mary Korytkowski ◽  
...  

Abstract Although diabetes research centers are well defined by National Institutes of Health, there is no clear definition for clinical Diabetes Centers of Excellence (DCOEs). There are multiple clinical diabetes centers across the United States, some established with philanthropic funding; however, it is not clear what defines a DCOE from a clinical perspective and what the future will be for these centers. In this Perspective we propose a framework to guide advancement for DCOEs. With the shift toward value-based purchasing and reimbursement and away from fee for service, defining the procedures for broader implementation of DCOEs as a way to improve population health and patient care experience (including quality and satisfaction) and reduce health care costs becomes critically important. It is prudent to implement new financial systems for compensating diabetes care that may not be provided by fiscally constrained private and academic medical centers. We envision that future clinical DCOEs would be composed of a well-defined infrastructure and six domains or pillars serving as the general guiding principles for developing expertise in diabetes care that can be readily demonstrated to stakeholders, including health care providers, patients, payers, and government agencies.


2006 ◽  
Vol 2 (11) ◽  
pp. 10
Author(s):  
JANE SALODOF MACNEIL
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document